FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608053089> ?p ?o ?g. }

• W2608053089 endingPage "360" @default.
• W2608053089 startingPage "353" @default.
• W2608053089 abstract "The present study aimed to investigate the potential role of microRNA-141-3p (miR-141-3p) in chronic inflammatory pain (CIP) by targeting the high-mobility group box1 (HMGB1) gene. In the in vitro study, BV2 microglial cells were selected and assigned into blank, lipopolysaccharide (LPS), miR-141-3p mimics, mimics control, miR-141-3p inhibitor, inhibitor control, miR-141-3p mimics+LPS, mimics control+ LPS, miR-141-3p inhibitor+LPS and inhibitor control+LPS groups. Ninety-six rats were randomly divided into 8 groups (12 rats in each group): blank control, model control, negative control (NC), miR-141-3p mimics+ complete Freund’s adjuvant (CFA), mimics control+CFA, HMGB1 short hairpin RNA (shRNA)+CFA, HMGB1 NC+CFA and miR-141-3p mimics+HMGB1 shRNA+CFA groups. The quantitative real-time PCR, western blotting, enzyme-linked immunosorbent assay and pain behavioral test were used to measure the miR-141-3p and HMGB1 mRNA expressions, HMGB1 protein expression, inflammatory cytokines levels, and thermal and mechanical pain thresholds, respectively. Compared with the blank, mimics control, inhibitor control and miR-141-3p mimics+LPS groups, the miR-141-3p mimics group had increased miR-141-3p expression and interleukin (IL)-10 levels, and had decreased mRNA and protein expressions of HMGB1 and the levels of IL-1β, tumor necrosis factor-α (TNF-α) and IL-6, whereas the opposite trend were found in the LPS, miR-141-3p inhibitor, mimics control+LPS and inhibitor control+LPS groups. Compared with the LPS, miR-141-3p inhibitor, mimics control+LPS and inhibitor control+LPS groups, the miR141-3p+LPS group had an obviously decreased expression of miR-141-3p and IL-10, increased mRNA and protein expressions of HMGB1 and the levels of IL-1β, TNF-α and IL-6. Compared with the rats in the blank control group, the miR-141-3p expression, IL-10 level, and thermal and mechanical pain thresholds decreased significantly, whereas the mRNA and protein expressions of HMGB1, IL-1β, TNF-α and IL-6 increased significantly in rats in the NC, mimics control+CFA and HMGB1 NC+ CFA groups. The miR-141-3p expression was increased in rats in the miR-141-3p mimics+HMGB1 shRNA+CFA group. Our study demonstrated that miR-141-3p can alleviate the CIP by downregulating the downstream target gene HMGB1." @default.
• W2608053089 created "2017-05-05" @default.
• W2608053089 creator A5003833400 @default.
• W2608053089 creator A5004966600 @default.
• W2608053089 creator A5015549511 @default.
• W2608053089 creator A5057243544 @default.
• W2608053089 creator A5063654622 @default.
• W2608053089 creator A5071563996 @default.
• W2608053089 date "2017-04-25" @default.
• W2608053089 modified "2023-09-26" @default.
• W2608053089 title "Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies" @default.
• W2608053089 cites W1029157723 @default.
• W2608053089 cites W1487845669 @default.
• W2608053089 cites W1767680910 @default.
• W2608053089 cites W1913069621 @default.
• W2608053089 cites W1968696997 @default.
• W2608053089 cites W1988469889 @default.
• W2608053089 cites W2021139007 @default.
• W2608053089 cites W2023219363 @default.
• W2608053089 cites W2029263000 @default.
• W2608053089 cites W2040484651 @default.
• W2608053089 cites W2046015931 @default.
• W2608053089 cites W2056334813 @default.
• W2608053089 cites W2056719183 @default.
• W2608053089 cites W2069176323 @default.
• W2608053089 cites W2075865806 @default.
• W2608053089 cites W2098586449 @default.
• W2608053089 cites W2105493915 @default.
• W2608053089 cites W2106362203 @default.
• W2608053089 cites W2107277218 @default.
• W2608053089 cites W2115216379 @default.
• W2608053089 cites W2118009469 @default.
• W2608053089 cites W2128058193 @default.
• W2608053089 cites W2140844751 @default.
• W2608053089 cites W2148267751 @default.
• W2608053089 cites W2161226217 @default.
• W2608053089 cites W2162741687 @default.
• W2608053089 cites W2168049386 @default.
• W2608053089 cites W2192080449 @default.
• W2608053089 cites W2343428693 @default.
• W2608053089 cites W2405955247 @default.
• W2608053089 cites W2538607840 @default.
• W2608053089 cites W311440096 @default.
• W2608053089 doi "https://doi.org/10.1038/gt.2017.28" @default.
• W2608053089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28440797" @default.
• W2608053089 hasPublicationYear "2017" @default.
• W2608053089 type Work @default.
• W2608053089 sameAs 2608053089 @default.
• W2608053089 citedByCount "28" @default.
• W2608053089 countsByYear W26080530892018 @default.
• W2608053089 countsByYear W26080530892019 @default.
• W2608053089 countsByYear W26080530892020 @default.
• W2608053089 countsByYear W26080530892021 @default.
• W2608053089 countsByYear W26080530892022 @default.
• W2608053089 countsByYear W26080530892023 @default.
• W2608053089 crossrefType "journal-article" @default.
• W2608053089 hasAuthorship W2608053089A5003833400 @default.
• W2608053089 hasAuthorship W2608053089A5004966600 @default.
• W2608053089 hasAuthorship W2608053089A5015549511 @default.
• W2608053089 hasAuthorship W2608053089A5057243544 @default.
• W2608053089 hasAuthorship W2608053089A5063654622 @default.
• W2608053089 hasAuthorship W2608053089A5071563996 @default.
• W2608053089 hasBestOaLocation W26080530891 @default.
• W2608053089 hasConcept C104317684 @default.
• W2608053089 hasConcept C127561419 @default.
• W2608053089 hasConcept C145059251 @default.
• W2608053089 hasConcept C150903083 @default.
• W2608053089 hasConcept C153911025 @default.
• W2608053089 hasConcept C173396325 @default.
• W2608053089 hasConcept C17991360 @default.
• W2608053089 hasConcept C190232843 @default.
• W2608053089 hasConcept C202751555 @default.
• W2608053089 hasConcept C203014093 @default.
• W2608053089 hasConcept C207001950 @default.
• W2608053089 hasConcept C2776914184 @default.
• W2608053089 hasConcept C2778754761 @default.
• W2608053089 hasConcept C2780545709 @default.
• W2608053089 hasConcept C55493867 @default.
• W2608053089 hasConcept C86803240 @default.
• W2608053089 hasConcept C98274493 @default.
• W2608053089 hasConceptScore W2608053089C104317684 @default.
• W2608053089 hasConceptScore W2608053089C127561419 @default.
• W2608053089 hasConceptScore W2608053089C145059251 @default.
• W2608053089 hasConceptScore W2608053089C150903083 @default.
• W2608053089 hasConceptScore W2608053089C153911025 @default.
• W2608053089 hasConceptScore W2608053089C173396325 @default.
• W2608053089 hasConceptScore W2608053089C17991360 @default.
• W2608053089 hasConceptScore W2608053089C190232843 @default.
• W2608053089 hasConceptScore W2608053089C202751555 @default.
• W2608053089 hasConceptScore W2608053089C203014093 @default.
• W2608053089 hasConceptScore W2608053089C207001950 @default.
• W2608053089 hasConceptScore W2608053089C2776914184 @default.
• W2608053089 hasConceptScore W2608053089C2778754761 @default.
• W2608053089 hasConceptScore W2608053089C2780545709 @default.
• W2608053089 hasConceptScore W2608053089C55493867 @default.
• W2608053089 hasConceptScore W2608053089C86803240 @default.
• W2608053089 hasConceptScore W2608053089C98274493 @default.
• W2608053089 hasIssue "6" @default.

• next